Assessment of intramyocardial hemorrhage with dark-blood T2*-weighted cardiovascular magnetic resonance.
Assessment of intramyocardial hemorrhage with dark-blood T2*-weighted cardiovascular magnetic resonance.
复制标题
DOI:
10.1186/s12968-021-00787-4
复制
发表时间:
2021-07-15
期刊:
影响因子:
--
通讯作者:
Dharmakumar R
中科院分区:
文献类型:
--
作者:
Guan X;Chen Y;Yang HJ;Zhang X;Ren D;Sykes J;Butler J;Han H;Zeng M;Prato FS;Dharmakumar R
Intramyocardial hemorrhage (IMH) within myocardial infarction (MI) is associated with major adverse cardiovascular events. Bright-blood T2*-based cardiovascular magnetic resonance (CMR) has emerged as the reference standard for non-invasive IMH detection. Despite this, the dark-blood T2*-based CMR is becoming interchangeably used with bright-blood T2*-weighted CMR in both clinical and preclinical settings for IMH detection. To date however, the relative merits of dark-blood T2*-weighted with respect to bright-blood T2*-weighted CMR for IMH characterization has not been studied. We investigated the diagnostic capacity of dark-blood T2*-weighted CMR against bright-blood T2*-weighted CMR for IMH characterization in clinical and preclinical settings. Hemorrhagic MI patients (n = 20) and canines (n = 11) were imaged in the acute and chronic phases at 1.5 and 3 T with dark- and bright-blood T2*-weighted CMR. Imaging characteristics (Relative signal-to-noise (SNR), Relative contrast-to-noise (CNR), IMH Extent) and diagnostic performance (sensitivity, specificity, accuracy, area-under-the-curve, and inter-observer variability) of dark-blood T2*-weighted CMR for IMH characterization were assessed relative to bright-blood T2*-weighted CMR. At both clinical and preclinical settings, compared to bright-blood T2*-weighted CMR, dark-blood T2*-weighted images had significantly lower SNR, CNR and reduced IMH extent (all p < 0.05). Dark-blood T2*-weighted CMR also demonstrated weaker sensitivity, specificity, accuracy, and inter-observer variability compared to bright-blood T2*-weighted CMR (all p < 0.05). These observations were consistent across infarct age and imaging field strengths. While IMH can be visible on dark-blood T2*-weighted CMR, the overall conspicuity of IMH is significantly reduced compared to that observed in bright-blood T2*-weighted images, across infarct age in clinical and preclinical settings at 1.5 and 3 T. Hence, bright-blood T2*-weighted CMR would be preferable for clinical use since dark-blood T2*-weighted CMR carries the potential to misclassify hemorrhagic MIs as non-hemorrhagic MIs.
登录
查看更多内容
DOI:
10.1186/s12968-017-0389-8
发表时间:
2017-10-09
期刊:
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子:
--
作者:
Messroghli DR;Moon JC;Ferreira VM;Grosse-Wortmann L;He T;Kellman P;Mascherbauer J;Nezafat R;Salerno M;Schelbert EB;Taylor AJ;Thompson R;Ugander M;van Heeswijk RB;Friedrich MG
通讯作者:
Friedrich MG
DOI:
10.1161/circimaging.113.001541
发表时间:
2014-05
期刊:
Circulation. Cardiovascular imaging
影响因子:
--
作者:
Kali A;Cokic I;Tang RL;Yang HJ;Sharif B;Marbán E;Li D;Berman DS;Dharmakumar R
通讯作者:
Dharmakumar R
影响因子:
19.7
作者:
Kali, Avinash;Tang, Richard L. Q.;Dharmakumar, Rohan
通讯作者:
Dharmakumar, Rohan
影响因子:
14
作者:
Kumar, Andreas;Green, Jordin D.;Friedrich, Matthias G.
通讯作者:
Friedrich, Matthias G.
影响因子:
3.3
作者:
Liguori, Carlo;Di Giampietro, Ilenia;Zobel, Bruno Beomonte
通讯作者:
Zobel, Bruno Beomonte